168 related articles for article (PubMed ID: 34165262)
21. Risk factors and outcomes associated with recurrent autoimmune hepatitis following liver transplantation.
Montano-Loza AJ; Ronca V; Ebadi M; Hansen BE; Hirschfield G; Elwir S; Alsaed M; Milkiewicz P; Janik MK; Marschall HU; Burza MA; Efe C; Calışkan AR; Harputluoglu M; Kabaçam G; Terrabuio D; de Quadros Onofrio F; Selzner N; Bonder A; Parés A; Llovet L; Akyıldız M; Arikan C; Manns MP; Taubert R; Weber AL; Schiano TD; Haydel B; Czubkowski P; Socha P; Ołdak N; Akamatsu N; Tanaka A; Levy C; Martin EF; Goel A; Sedki M; Jankowska I; Ikegami T; Rodriguez M; Sterneck M; Weiler-Normann C; Schramm C; Donato MF; Lohse A; Andrade RJ; Patwardhan VR; van Hoek B; Biewenga M; Kremer AE; Ueda Y; Deneau M; Pedersen M; Mayo MJ; Floreani A; Burra P; Secchi MF; Beretta-Piccoli BT; Sciveres M; Maggiore G; Jafri SM; Debray D; Girard M; Lacaille F; Lytvyak E; Mason AL; Heneghan M; Oo YH;
J Hepatol; 2022 Jul; 77(1):84-97. PubMed ID: 35143897
[TBL] [Abstract][Full Text] [Related]
22. Role of age in presentation, response to therapy and outcome of autoimmune hepatitis.
Baven-Pronk MAMC; Biewenga M; van Silfhout JJ; van den Berg AP; van Buuren HR; Verwer BJ; van Nieuwkerk CMJ; Bouma G; van Hoek B
Clin Transl Gastroenterol; 2018 Jul; 9(6):165. PubMed ID: 29961755
[TBL] [Abstract][Full Text] [Related]
23. Risk factors for developing de novo autoimmune hepatitis associated with anti-glutathione S-transferase T1 antibodies after liver transplantation.
Salcedo M; Rodríguez-Mahou M; Rodríguez-Sainz C; Rincón D; Alvarez E; Vicario JL; Catalina MV; Matilla A; Ripoll C; Clemente G; Bañares R
Liver Transpl; 2009 May; 15(5):530-9. PubMed ID: 19399747
[TBL] [Abstract][Full Text] [Related]
24. Prognosis of acute severe autoimmune hepatitis (AS-AIH): the role of corticosteroids in modifying outcome.
Yeoman AD; Westbrook RH; Zen Y; Bernal W; Al-Chalabi T; Wendon JA; O'Grady JG; Heneghan MA
J Hepatol; 2014 Oct; 61(4):876-82. PubMed ID: 24842305
[TBL] [Abstract][Full Text] [Related]
25. Prediction of short- and long-term outcome in patients with autoimmune hepatitis.
Kirstein MM; Metzler F; Geiger E; Heinrich E; Hallensleben M; Manns MP; Vogel A
Hepatology; 2015 Nov; 62(5):1524-35. PubMed ID: 26178791
[TBL] [Abstract][Full Text] [Related]
26. Natural History of Patients Presenting with Autoimmune Hepatitis and Coincident Nonalcoholic Fatty Liver Disease.
De Luca-Johnson J; Wangensteen KJ; Hanson J; Krawitt E; Wilcox R
Dig Dis Sci; 2016 Sep; 61(9):2710-20. PubMed ID: 27262844
[TBL] [Abstract][Full Text] [Related]
27. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of C-reactive protein in cirrhosis: external validation from the CANONIC cohort.
Cervoni JP; Amorós À; Bañares R; Luis Montero J; Soriano G; Weil D; Moreau R; Pavesi M; Thévenot T; Di Martino V;
Eur J Gastroenterol Hepatol; 2016 Sep; 28(9):1028-34. PubMed ID: 27271159
[TBL] [Abstract][Full Text] [Related]
29. The natural history of autoimmune hepatitis presenting with jaundice.
Panayi V; Froud OJ; Vine L; Laurent P; Woolson KL; Hunter JG; Madden RG; Miller C; Palmer J; Harris N; Mathew J; Stableforth B; Murray IA; Dalton HR
Eur J Gastroenterol Hepatol; 2014 Jun; 26(6):640-5. PubMed ID: 24694760
[TBL] [Abstract][Full Text] [Related]
30. Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort study.
Plagiannakos CG; Hirschfield GM; Lytvyak E; Roberts SB; Ismail M; Gulamhusein AF; Selzner N; Qumosani KM; Worobetz L; Hercun J; Vincent C; Flemming JA; Swain MG; Cheung A; Chen T; Grbic D; Peltekain K; Mason AL; Montano-Loza AJ; Hansen BE;
J Hepatol; 2024 Mar; ():. PubMed ID: 38527524
[TBL] [Abstract][Full Text] [Related]
31. Autoimmune hepatitis in children--impact of cirrhosis at presentation on natural history and long-term outcome.
Radhakrishnan KR; Alkhouri N; Worley S; Arrigain S; Hupertz V; Kay M; Yerian L; Wyllie R; Feldstein AE
Dig Liver Dis; 2010 Oct; 42(10):724-8. PubMed ID: 20163994
[TBL] [Abstract][Full Text] [Related]
32. Copeptin is an independent prognostic factor for transplant-free survival in cirrhosis.
Kerbert AJ; Weil D; Verspaget HW; Moréno JP; van Hoek B; Cervoni JP; Di Martino V; Coenraad MJ; Thevenot T
Liver Int; 2016 Apr; 36(4):530-7. PubMed ID: 26502363
[TBL] [Abstract][Full Text] [Related]
33. Hepatic and Extrahepatic Characteristics of Autoimmune Hepatitis: A 23-year Hospital-Based Cohort Study.
Chang ML; Le PH; Chen WT; Chen TD; Chien RN
Dig Dis Sci; 2024 Jun; 69(6):2193-2203. PubMed ID: 38653947
[TBL] [Abstract][Full Text] [Related]
34. Primary liver transplantation for autoimmune hepatitis: a comparative analysis of the European Liver Transplant Registry.
Schramm C; Bubenheim M; Adam R; Karam V; Buckels J; O'Grady JG; Jamieson N; Pollard S; Neuhaus P; Manns MM; Porte R; Castaing D; Paul A; Traynor O; Garden J; Friman S; Ericzon BG; Fischer L; Vitko S; Krawczyk M; Metselaar HJ; Foss A; Kilic M; Rolles K; Burra P; Rogiers X; Lohse AW;
Liver Transpl; 2010 Apr; 16(4):461-9. PubMed ID: 20373456
[TBL] [Abstract][Full Text] [Related]
35. Increased Mortality Risk in Autoimmune Hepatitis: A Nationwide Population-Based Cohort Study With Histopathology.
Sharma R; Verna EC; Söderling J; Roelstraete B; Hagström H; Ludvigsson JF
Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2636-2647.e13. PubMed ID: 33065308
[TBL] [Abstract][Full Text] [Related]
36. The impact of ethnicity on the natural history of autoimmune hepatitis.
Verma S; Torbenson M; Thuluvath PJ
Hepatology; 2007 Dec; 46(6):1828-35. PubMed ID: 17705297
[TBL] [Abstract][Full Text] [Related]
37. Liver transplanted patients with preoperative autoimmune hepatitis and immunological disorders are at increased risk for Post-Transplant Lymphoproliferative Disease (PTLD).
Zimmermann T; Hoppe-Lotichius M; Tripkovic V; Barreiros AP; Wehler TC; Zimmermann A; Schattenberg JM; Heise M; Biesterfeld S; Galle PR; Otto G; Schuchmann M
Eur J Intern Med; 2010 Jun; 21(3):208-15. PubMed ID: 20493424
[TBL] [Abstract][Full Text] [Related]
38. Clinical and prognostic implications of acute onset of Autoimmune Hepatitis: An Italian multicentre study.
Muratori P; Carbone M; Stangos G; Perini L; Lalanne C; Ronca V; Cazzagon N; Bianchi G; Lenzi M; Floreani A; Invernizzi P; Muratori L
Dig Liver Dis; 2018 Jul; 50(7):698-702. PubMed ID: 29567415
[TBL] [Abstract][Full Text] [Related]
39. Long-term outcome of liver transplantation for autoimmune hepatitis: A French nationwide study over 30 years.
Chouik Y; Chazouillères O; Francoz C; De Martin E; Guillaud O; Abergel A; Altieri M; Barbier L; Besch C; Conti F; Corpechot C; Dharancy S; Durand F; Duvoux C; Gugenheim J; Hardwigsen J; Hilleret MN; Houssel-Debry P; Kamar N; Maucort-Boulch D; Minello A; Neau-Cransac M; Pageaux GP; Radenne S; Roux O; Saliba F; Serée O; Samuel D; Vanlemmens C; Woehl-Jaegle ML; Leroy V; Duclos-Vallée JC; Dumortier J
Liver Int; 2023 May; 43(5):1068-1079. PubMed ID: 36825353
[TBL] [Abstract][Full Text] [Related]
40. Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy.
Verma S; Gunuwan B; Mendler M; Govindrajan S; Redeker A
Am J Gastroenterol; 2004 Aug; 99(8):1510-6. PubMed ID: 15307869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
